SIRT1 in the brain—connections with aging-associated disorders and lifespan

Frontiers in Cellular Neuroscience

Volumn 9, Issue , 2015, Pages

  Ng, Fanny ^a   Wijaya, Laura ^a   Tang, Bor Luen ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Aging; Cognition; Metabolism; Neurodegeneration; SIRT1

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HISTONE DEACETYLASE; SIRTUIN 1; SOMATOMEDIN C;

AGING; ASTROCYTOSIS; CIRCADIAN RHYTHM; COGNITION; DOWN REGULATION; ENERGY METABOLISM; LIFESPAN; NERVE CELL DEGENERATION; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE FIBER GROWTH; NEUROPROTECTION; PROTEIN EXPRESSION; REVIEW; UPREGULATION;

EID: 84938417700     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00064     Document Type: Review

References (168)

1. Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., et al. (2007). Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res. 100, 1512-1521. doi: 10.1161/01.res.0000267723.65696.4a
2. Anderson, R. M., Bitterman, K. J., Wood, J. G., Medvedik, O., and Sinclair, D. A. (2003). Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 423, 181-185. doi: 10.1038/nature01578
3. Asher, G., Gatfield, D., Stratmann, M., Reinke, H., Dibner, C., Kreppel, F., et al. (2008). SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 134, 317-328. doi: 10.1016/j.cell.2008.06.050
4. Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., and Jones, E. (2011). Alzheimer's disease. Lancet 377, 1019-1031. doi: 10.1016/S0140-6736(10)61349-9
5. Bandyopadhyay, S., Goldstein, L. E., Lahiri, D. K., and Rogers, J. T. (2007). Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease. Curr. Med. Chem. 14, 2848-2864. doi: 10.2174/092986707782360060
6. Baptista, T., Graça, I., Sousa, E. J., Oliveira, A. I., Costa, N. R., Costa-Pinheiro, P., et al. (2013). Regulation of histone H2A.Z expression is mediated by sirtuin 1 in prostate cancer. Oncotarget 4, 1673-1685.
7. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., et al. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342. doi: 10.1038/nature05354
8. Baur, J. A., Ungvari, Z., Minor, R. K., Le Couteur, D. G., and de Cabo, R. (2012). Are sirtuins viable targets for improving healthspan and lifespan? Nat. Rev. Drug Discov. 11, 443-461. doi: 10.1038/nrd3738
9. Bishop, N. A., Lu, T., and Yankner, B. A. (2010). Neural mechanisms of ageing and cognitive decline. Nature 464, 529-535. doi: 10.1038/nature08983
10. Blander, G., and Guarente, L. (2004). The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 73, 417-435. doi: 10.1146/annurev.biochem.73.011303.073651
11. Bonda, D. J., Lee, H. G., Camins, A., Pallàs, M., Casadesus, G., Smith, M. A., et al. (2011). The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurol. 10, 275-279. doi: 10.1016/s1474-4422(11)70013-8
12. Bordone, L., Motta, M. C., Picard, F., Robinson, A., Jhala, U. S., Apfeld, J., et al. (2006). Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol. 4:e31. doi: 10.1371/journal.pbio.0040031
13. Braidy, N., Jayasena, T., Poljak, A., and Sachdev, P. S. (2012). Sirtuins in cognitive ageing and Alzheimer's disease. Curr. Opin. Psychiatry 25, 226-230. doi: 10.1097/YCO.0b013e32835112c1
14. Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., et al. (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015. doi: 10.1126/science.1094637
15. Burnett, C., Valentini, S., Cabreiro, F., Goss, M., Somogyvári, M., Piper, M. D., et al. (2011). Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 477, 482-485. doi: 10.1038/nature10296
16. Cabeza, R., Anderson, N. D., Locantore, J. K., and McIntosh, A. R. (2002). Aging gracefully: compensatory brain activity in high-performing older adults. Neuroimage 17, 1394-1402. doi: 10.1006/nimg.2002.1280
17. Cakir, I., Perello, M., Lansari, O., Messier, N. J., Vaslet, C. A., and Nillni, E. A. (2009). Hypothalamic Sirt1 regulates food intake in a rodent model system. PLoS One 4:e8322. doi: 10.1371/journal.pone.0008322
18. Cantó, C., and Auwerx, J. (2009a). Caloric restriction, SIRT1 and longevity. Trends Endocrinol. Metab. 20, 325-331. doi: 10.1016/j.tem.2009.03.008
19. Cantó, C., and Auwerx, J. (2009b). PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 20, 98-105. doi: 10.1097/MOL.0b013e328328d0a4
20. Chakraborty, C., and Doss, C. G. P. (2013). Sirtuins family-recent development as a drug target for aging, metabolism and age related diseases. Curr. Drug Targets 14, 666-675. doi: 10.2174/1389450111314060008
21. Chalkiadaki, A., and Guarente, L. (2012). Sirtuins mediate mammalian metabolic responses to nutrient availability. Nat. Rev. Endocrinol. 8, 287-296. doi: 10.1038/nrendo.2011.225
22. Chang, H. C., and Guarente, L. (2013). SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell 153, 1448-1460. doi: 10.1016/j.cell.2013.05.027
23. Chang, H. C., and Guarente, L. (2014). SIRT1 and other sirtuins in metabolism. Trends Endocrinol. Metab. 25, 138-145. doi: 10.1016/j.tem.2013.12.001
24. Chaudhary, N., and Pfluger, P. T. (2009). Metabolic benefits from Sirt1 and Sirt1 activators. Curr. Opin. Clin. Nutr. Metab. Care 12, 431-437. doi: 10.1097/MCO.0b013e32832cdaae
25. Chen, J., Zhou, Y., Mueller-Steiner, S., Chen, L. F., Kwon, H., Yi, S., et al. (2005). SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-κB signaling. J. Biol. Chem. 280, 40364-40374. doi: 10.1074/jbc.m509329200
26. Cho, S. H., Chen, J. A., Sayed, F., Ward, M. E., Gao, F., Nguyen, T. A., et al. (2015). SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1β. J. Neurosci. 35, 807-818. doi: 10.1523/JNEUROSCI.2939-14.2015
27. Chung, K. W., Kim, D. H., Park, M. H., Choi, Y. J., Kim, N. D., Lee, J., et al. (2013). Recent advances in calorie restriction research on aging. Exp. Gerontol. 48, 1049-1053. doi: 10.1016/j.exger.2012.11.007
28. Codocedo, J. F., Allard, C., Godoy, J. A., Varela-Nallar, L., and Inestrosa, N. C. (2012). SIRT1 regulates dendritic development in hippocampal neurons. PLoS One 7:e47073. doi: 10.1371/journal.pone.0047073
29. Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., et al. (2004). Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390-392. doi: 10.1126/science.1099196
30. Cohen, D. E., Supinski, A. M., Bonkowski, M. S., Donmez, G., and Guarente, L. P. (2009). Neuronal SIRT1 regulates endocrine and behavioral responses to calorie restriction. Genes Dev. 23, 2812-2817. doi: 10.1101/gad.1839209
31. Corrigan, F., Vink, R., Blumbergs, P. C., Masters, C. L., Cappai, R., and van den Heuvel, C. (2012). sAPPα rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury. J. Neurochem. 122, 208-220. doi: 10.1111/j.1471-4159.2012.07761.x
32. Cyr, N. E., Steger, J. S., Toorie, A. M., Yang, J. Z., Stuart, R., and Nillni, E. A. (2014). Central Sirt1 regulates body weight and energy expenditure along with the POMC-derived peptide α-MSH and the processing enzyme CPE production in diet-induced obese male rats. Endocrinology 155, 2423-2435. doi: 10.1210/en.2013-1998
33. Dietrich, M. O., Antunes, C., Geliang, G., Liu, Z. W., Borok, E., Nie, Y., et al. (2010). Agrp neurons mediate Sirt1's action on the melanocortin system and energy balance: roles for Sirt1 in neuronal firing and synaptic plasticity. J. Neurosci. 30, 11815-11825. doi: 10.1523/JNEUROSCI.2234-10.2010
34. Dobbin, M. M., Madabhushi, R., Pan, L., Chen, Y., Kim, D., Gao, J., et al. (2013). SIRT1 collaborates with ATM and HDAC1 to maintain genomic stability in neurons. Nat. Neurosci. 16, 1008-1015. doi: 10.1038/nn.3460
35. Donmez, G., Arun, A., Chung, C. Y., McLean, P. J., Lindquist, S., and Guarente, L. (2012). SIRT1 protects against α-synuclein aggregation by activating molecular chaperones. J. Neurosci. 32, 124-132. doi: 10.1523/JNEUROSCI.3442-11.2012
36. Donmez, G., and Outeiro, T. F. (2013). SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol. Med. 5, 344-352. doi: 10.1002/emmm.201302451
37. Donmez, G., Wang, D., Cohen, D. E., and Guarente, L. (2010). SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 142, 320-332. doi: 10.1016/j.cell.2010.06.020
38. Fabrizio, P., Gattazzo, C., Battistella, L., Wei, M., Cheng, C., McGrew, K., et al. (2005). Sir2 blocks extreme life-span extension. Cell 123, 655-667. doi: 10.1016/j.cell.2005.08.042
39. Falone, S., D'Alessandro, A., Mirabilio, A., Cacchio, M., Di Ilio, C., Di Loreto, S., et al. (2012). Late-onset running biphasically improves redox balance, energy- and methylglyoxal-related status, as well as SIRT1 expression in mouse hippocampus. PLoS One 7:e48334. doi: 10.1371/journal.pone.0048334
40. Gan, L., and Mucke, L. (2008). Paths of convergence: sirtuins in aging and neurodegeneration. Neuron 58, 10-14. doi: 10.1016/j.neuron.2008.03.015
41. Gao, J., Wang, W. Y., Mao, Y. W., Gräff, J., Guan, J. S., Pan, L., et al. (2010). A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 466, 1105-1109. doi: 10.1038/nature09271
42. Gräff, J., and Tsai, L. H. (2013). The potential of HDAC inhibitors as cognitive enhancers. Annu. Rev. Pharmacol. Toxicol. 53, 311-330. doi: 10.1146/annurev-pharmtox-011112-140216
43. Green, K. N., Steffan, J. S., Martinez-Coria, H., Sun, X., Schreiber, S. S., Thompson, L. M., et al. (2008). Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J. Neurosci. 28, 11500-11510. doi: 10.1523/JNEUROSCI.3203-08.2008
44. Guarente, L. (2013). Calorie restriction and sirtuins revisited. Genes Dev. 27, 2072-2085. doi: 10.1101/gad.227439.113
45. Guo, W., Qian, L., Zhang, J., Zhang, W., Morrison, A., Hayes, P., et al. (2011). Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling. J. Neurosci. Res. 89, 1723-1736. doi: 10.1002/jnr.22725
46. Guy, J., Cheval, H., Selfridge, J., and Bird, A. (2011). The role of MeCP2 in the brain. Annu. Rev. Cell Dev. Biol. 27, 631-652. doi: 10.1146/annurev-cellbio-092910-154121
47. Haigis, M. C., and Sinclair, D. A. (2010). Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 5, 253-295. doi: 10.1146/annurev.pathol.4.110807.092250
48. Hasegawa, K., and Yoshikawa, K. (2008). Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons. J. Neurosci. 28, 8772-8784. doi: 10.1523/JNEUROSCI.3052-08.2008
49. Hauser, P. S., and Ryan, R. O. (2013). Impact of apolipoprotein E on Alzheimer's disease. Curr. Alzheimer Res. 10, 809-817. doi: 10.2174/15672050113109990156
50. Hayakawa, T., Iwai, M., Aoki, S., Takimoto, K., Maruyama, M., Maruyama, W., et al. (2015). SIRT1 suppresses the senescence-associated secretory phenotype through epigenetic gene regulation. PLoS One 10:e0116480. doi: 10.1371/journal.pone.0116480
51. Hernández-Jiménez, M., Hurtado, O., Cuartero, M. I., Ballesteros, I., Moraga, A., Pradillo, J. M., et al. (2013). Silent information regulator 1 protects the brain against cerebral ischemic damage. Stroke 44, 2333-2337. doi: 10.1161/STROKEAHA.113.001715
52. Herranz, D., Muñoz-Martin, M., Cañamero, M., Mulero, F., Martinez-Pastor, B., Fernandez-Capetillo, O., et al. (2010). Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat. Commun. 1:3. doi: 10.1038/ncomms1001
53. Herskovits, A. Z., and Guarente, L. (2014). SIRT1 in neurodevelopment and brain senescence. Neuron 81, 471-483. doi: 10.1016/j.neuron.2014.01.028
54. Heyward, F. D., Walton, R. G., Carle, M. S., Coleman, M. A., Garvey, W. T., and Sweatt, J. D. (2012). Adult mice maintained on a high-fat diet exhibit object location memory deficits and reduced hippocampal SIRT1 gene expression. Neurobiol. Learn. Mem. 98, 25-32. doi: 10.1016/j.nlm.2012.04.005
55. Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D. B., et al. (2010). SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121-125. doi: 10.1038/nature08778
56. Huang, H., and Tindall, D. J. (2007). Dynamic FoxO transcription factors. J. Cell Sci. 120, 2479-2487. doi: 10.1242/jcs.001222
57. Ichi, S., Boshnjaku, V., Shen, Y. W., Mania-Farnell, B., Ahlgren, S., Sapru, S., et al. (2011). Role of Pax3 acetylation in the regulation of Hes1 and Neurog2. Mol. Biol. Cell 22, 503-512. doi: 10.1091/mbc.e10-06-0541
58. Imai, S., Armstrong, C. M., Kaeberlein, M., and Guarente, L. (2000). Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795-800. doi: 10.1038/35001622
59. Jeong, H., Cohen, D. E., Cui, L., Supinski, A., Savas, J. N., Mazzulli, J. R., et al. (2011). Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat. Med. 18, 159-165. doi: 10.1038/nm.2559
60. Jiang, M., Wang, J., Fu, J., Du, L., Jeong, H., West, T., et al. (2011). Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat. Med. 18, 153-158. doi: 10.1038/nm.2558
61. Julien, C., Tremblay, C., Emond, V., Lebbadi, M., Salem, N., Bennett, D. A., et al. (2009). Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J. Neuropathol. Exp. Neurol. 68, 48-58. doi: 10.1097/NEN.0b013e3181922348
62. Kaeberlein, M., McVey, M., and Guarente, L. (1999). The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13, 2570-2580. doi: 10.1101/gad.13.19.2570
63. Kaeberlein, M., and Powers, R. W. (2007). Sir2 and calorie restriction in yeast: a skeptical perspective. Ageing Res. Rev. 6, 128-140. doi: 10.1016/j.arr.2007.04.001
64. Kakefuda, K., Fujita, Y., Oyagi, A., Hyakkoku, K., Kojima, T., Umemura, K., et al. (2009). Sirtuin 1 overexpression mice show a reference memory deficit, but not neuroprotection. Biochem. Biophys. Res. Commun. 387, 784-788. doi: 10.1016/j.bbrc.2009.07.119
65. Kanfi, Y., Naiman, S., Amir, G., Peshti, V., Zinman, G., Nahum, L., et al. (2012). The sirtuin SIRT6 regulates lifespan in male mice. Nature 483, 218-221. doi: 10.1038/nature10815
66. Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., et al. (2007). SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 26, 3169-3179. doi: 10.1038/sj.emboj.7601758
67. Kimura, K. D., Tissenbaum, H. A., Liu, Y., and Ruvkun, G. (1997). daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277, 942-946. doi: 10.1126/science.277.5328.942
68. Knight, C. M., Gutierrez-Juarez, R., Lam, T. K. T., Arrieta-Cruz, I., Huang, L., Schwartz, G., et al. (2011). Mediobasal hypothalamic SIRT1 is essential for resveratrol's effects on insulin action in rats. Diabetes 60, 2691-2700. doi: 10.2337/db10-0987
69. Kurata, T., Miyazaki, K., Kozuki, M., Panin, V. L., Morimoto, N., Ohta, Y., et al. (2011). Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice. Brain Res. 1371, 161-170. doi: 10.1016/j.brainres.2010.11.067
70. Kyrylenko, S., Kyrylenko, O., Suuronen, T., and Salminen, A. (2003). Differential regulation of the Sir2 histone deacetylase gene family by inhibitors of class I and II histone deacetylases. Cell. Mol. Life Sci. 60, 1990-1997. doi: 10.1007/s00018-003-3090-z
71. Lalla, R., and Donmez, G. (2013). The role of sirtuins in Alzheimer's disease. Front. Aging Neurosci. 5:16. doi: 10.3389/fnagi.2013.00016
72. Laurent, G., de Boer, V. C. J., Finley, L. W. S., Sweeney, M., Lu, H., Schug, T. T., et al. (2013a). SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation. Mol. Cell. Biol. 33, 4552-4561. doi: 10.1128/MCB.00087-13
73. Laurent, G., German, N. J., Saha, A. K., de Boer, V. C. J., Davies, M., Koves, T. R., et al. (2013b). SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase. Mol. Cell 50, 686-698. doi: 10.1016/j.molcel.2013.05.012
74. Lee, H. R., Shin, H. K., Park, S. Y., Kim, H. Y., Lee, W. S., Rhim, B. Y., et al. (2014). Cilostazol suppresses β-amyloid production by activating a disintegrin and metalloproteinase 10 via the upregulation of SIRT1-coupled retinoic acid receptor-β. J. Neurosci. Res. 92, 1581-1590. doi: 10.1002/jnr.23421
75. Li, X. (2013). SIRT1 and energy metabolism. Acta Biochim. Biophys. Sin. (Shanghai) 45, 51-60. doi: 10.1093/abbs/gms108
76. Li, X. H., Chen, C., Tu, Y., Sun, H. T., Zhao, M. L., Cheng, S. X., et al. (2013). Sirt1 promotes axonogenesis by deacetylation of Akt and inactivation of GSK3. Mol. Neurobiol. 48, 490-499. doi: 10.1007/s12035-013-8437-3
77. Li, Y., Xu, W., McBurney, M. W., and Longo, V. D. (2008). SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab. 8, 38-48. doi: 10.1016/j.cmet.2008.05.004
78. Lin, S. J., Defossez, P. A., and Guarente, L. (2000). Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289, 2126-2128. doi: 10.1126/science.289.5487.2126
79. Liu, L., Arun, A., Ellis, L., Peritore, C., and Donmez, G. (2012). Sirtuin 2 (SIRT2) enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via deacetylating forkhead box O3a (Foxo3a) and activating Bim protein. J. Biol. Chem. 287, 32307-32311. doi: 10.1074/jbc.c112.403048
80. Liu, D., Gharavi, R., Pitta, M., Gleichmann, M., and Mattson, M. P. (2009). Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons. Neuromolecular Med. 11, 28-42. doi: 10.1007/s12017-009-8058-1
81. Liu, D. J., Hammer, D., Komlos, D., Chen, K. Y., Firestein, B. L., and Liu, A. Y. C. (2014). SIRT1 knockdown promotes neural differentiation and attenuates the heat shock response. J. Cell. Physiol. 229, 1224-1235. doi: 10.1002/jcp.24556
82. Liu, C. M., Wang, R. Y., Saijilafu, Jiao, Z. X., Zhang, B. Y., and Zhou, F. Q. (2013a). MicroRNA-138 and SIRT1 form a mutual negative feedback loop to regulate mammalian axon regeneration. Genes Dev. 27, 1473-1483. doi: 10.1101/gad.209619.112
83. Liu, Y., Yao, Z., Zhang, L., Zhu, H., Deng, W., and Qin, C. (2013b). Insulin induces neurite outgrowth via SIRT1 in SH-SY5Y cells. Neuroscience 238, 371-380. doi: 10.1016/j.neuroscience.2013.01.034
84. Liyanage, V. R. B., and Rastegar, M. (2014). Rett syndrome and MeCP2. Neuromolecular Med. 16, 231-264. doi: 10.1007/s12017-014-8295-9
85. Lombard, D. B., Pletcher, S. D., Cantó, C., and Auwerx, J. (2011). Ageing: longevity hits a roadblock. Nature 477, 410-411. doi: 10.1038/477410a
86. Lu, M., Sarruf, D. A., Li, P., Osborn, O., Sanchez-Alavez, M., Talukdar, S., et al. (2013). Neuronal Sirt1 deficiency increases insulin sensitivity in both brain and peripheral tissues. J. Biol. Chem. 288, 10722-10735. doi: 10.1074/jbc.M112.443606
87. Ma, T., Zhao, Y., Kwak, Y. D., Yang, Z., Thompson, R., Luo, Z., et al. (2009). Statin's excitoprotection is mediated by sAPP and the subsequent attenuation of calpain-induced truncation events, likely via rho-ROCK signaling. J. Neurosci. 29, 11226-11236. doi: 10.1523/JNEUROSCI.6150-08.2009
88. Masri, S., Rigor, P., Cervantes, M., Ceglia, N., Sebastian, C., Xiao, C., et al. (2014). Partitioning circadian transcription by SIRT6 leads to segregated control of cellular metabolism. Cell 158, 659-672. doi: 10.1016/j.cell.2014.06.050
89. Masri, S., and Sassone-Corsi, P. (2014). Sirtuins and the circadian clock: bridging chromatin and metabolism. Sci. Signal. 7:re6. doi: 10.1126/scisignal.2005685
90. Maury, E., Ramsey, K. M., and Bass, J. (2010). Circadian rhythms and metabolic syndrome: from experimental genetics to human disease. Circ. Res. 106, 447-462. doi: 10.1161/CIRCRESAHA.109.208355
91. Mercken, E. M., Hu, J., Krzysik-Walker, S., Wei, M., Li, Y., McBurney, M. W., et al. (2014). SIRT1 but not its increased expression is essential for lifespan extension in caloric-restricted mice. Aging Cell 13, 193-196. doi: 10.1111/acel.12151
92. Michán, S., Li, Y., Chou, M. M. H., Parrella, E., Ge, H., Long, J. M., et al. (2010). SIRT1 is essential for normal cognitive function and synaptic plasticity. J. Neurosci. 30, 9695-9707. doi: 10.1523/JNEUROSCI.0027-10.2010
93. Michan, S., and Sinclair, D. (2007). Sirtuins in mammals: insights into their biological function. Biochem. J. 404, 1-13. doi: 10.1042/bj20070140
94. Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., et al. (2007). Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712-716. doi: 10.1038/nature06261
95. Mitchell, S. J., Martin-Montalvo, A., Mercken, E. M., Palacios, H. H., Ward, T. M., Abulwerdi, G., et al. (2014). The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet. Cell Rep. 6, 836-843. doi: 10.1016/j.celrep.2014.01.031
96. Monteserin-Garcia, J., Al-Massadi, O., Seoane, L. M., Alvarez, C. V., Shan, B., Stalla, J., et al. (2013). Sirt1 inhibits the transcription factor CREB to regulate pituitary growth hormone synthesis. FASEB J. 27, 1561-1571. doi: 10.1096/fj.12-220129
97. Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S., and Schwartz, M. W. (2006). Central nervous system control of food intake and body weight. Nature 443, 289-295. doi: 10.1038/nature05026
98. Mudò, G., Mäkelä, J., Di Liberto, V., Tselykh, T. V., Olivieri, M., Piepponen, P., et al. (2012). Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease. Cell. Mol. Life Sci. 69, 1153-1165. doi: 10.1007/s00018-011-0850-z
99. Naiman, S., and Cohen, H. Y. (2012). The contentious history of sirtuin debates. Rambam Maimonides Med. J. 3:e0022. doi: 10.5041/RMMJ.10093
100. Nakahata, Y., Kaluzova, M., Grimaldi, B., Sahar, S., Hirayama, J., Chen, D., et al. (2008). The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 134, 329-340. doi: 10.1016/j.cell.2008.07.002
101. Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., and Sassone-Corsi, P. (2009). Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324, 654-657. doi: 10.1126/science.1170803
102. Ng, F., and Tang, B. L. (2013). When is Sirt1 activity bad for dying neurons? Front. Cell. Neurosci. 7:186. doi: 10.3389/fncel.2013.00186
103. North, B. J., Rosenberg, M. A., Jeganathan, K. B., Hafner, A. V., Michan, S., Dai, J., et al. (2014). SIRT2 induces the checkpoint kinase BubR1 to increase lifespan. EMBO J. 33, 1438-1453. doi: 10.15252/embj.201386907
104. Ogawa, T., Wakai, C., Saito, T., Murayama, A., Mimura, Y., Youfu, S., et al. (2011). Distribution of the longevity gene product, SIRT1, in developing mouse organs. Congenit. Anom. (Kyoto) 51, 70-79. doi: 10.1111/j.1741-4520.2010.00304.x
105. Ogg, S., Paradis, S., Gottlieb, S., Patterson, G. I., Lee, L., Tissenbaum, H. A., et al. (1997). The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C elegans. Nature 389, 994-999. doi: 10.1038/40194
106. Outeiro, T. F., Kontopoulos, E., Altmann, S. M., Kufareva, I., Strathearn, K. E., Amore, A. M., et al. (2007). Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science 317, 516-519. doi: 10.1126/science.1143780
107. Pallàs, M., Pizarro, J. G., Gutierrez-Cuesta, J., Crespo-Biel, N., Alvira, D., Tajes, M., et al. (2008). Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neuroscience 154, 1388-1397. doi: 10.1016/j.neuroscience.2008.04.065
108. Park, S., Mori, R., and Shimokawa, I. (2013). Do sirtuins promote mammalian longevity? A critical review on its relevance to the longevity effect induced by calorie restriction. Mol. Cells 35, 474-480. doi: 10.1007/s10059-013-0130-x
109. Parker, J. A., Arango, M., Abderrahmane, S., Lambert, E., Tourette, C., Catoire, H., et al. (2005). Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat. Genet. 37, 349-350. doi: 10.1038/ng1534
110. Pedrini, S., Carter, T. L., Prendergast, G., Petanceska, S., Ehrlich, M. E., and Gandy, S. (2005). Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK. PLoS Med. 2:e18. doi: 10.1371/journal.pmed.0020018
111. Prozorovski, T., Schulze-Topphoff, U., Glumm, R., Baumgart, J., Schröter, F., Ninnemann, O., et al. (2008). Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat. Cell Biol. 10, 385-394. doi: 10.1038/ncb1700
112. Qiang, L., Wang, L., Kon, N., Zhao, W., Lee, S., Zhang, Y., et al. (2012). Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell 150, 620-632. doi: 10.1016/j.cell.2012.06.027
113. Qin, W., Chachich, M., Lane, M., Roth, G., Bryant, M., de Cabo, R., et al. (2006a). Calorie restriction attenuates Alzheimer's disease type brain amyloidosis in Squirrel monkeys (Saimiri sciureus). J. Alzheimers Dis. 10, 417-422.
114. Qin, W., Yang, T., Ho, L., Zhao, Z., Wang, J., Chen, L., et al. (2006b). Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem. 281, 21745-21754. doi: 10.1074/jbc.m602909200
115. Quintas, A., de Solís, A. J., Díez-Guerra, F. J., Carrascosa, J. M., and Bogónez, E. (2012). Age-associated decrease of SIRT1 expression in rat hippocampus: prevention by late onset caloric restriction. Exp. Gerontol. 47, 198-201. doi: 10.1016/j.exger.2011.11.010
116. Rafalski, V. A., Ho, P. P., Brett, J. O., Ucar, D., Dugas, J. C., Pollina, E. A., et al. (2013). Expansion of oligodendrocyte progenitor cells following SIRT1 inactivation in the adult brain. Nat. Cell Biol. 15, 614-624. doi: 10.1038/ncb2735
117. Ramadori, G., Fujikawa, T., Anderson, J., Berglund, E. D., Frazao, R., Michán, S., et al. (2011). SIRT1 deacetylase in SF1 neurons protects against metabolic imbalance. Cell Metab. 14, 301-312. doi: 10.1016/j.cmet.2011.06.014
118. Ramadori, G., Fujikawa, T., Fukuda, M., Anderson, J., Morgan, D. A., Mostoslavsky, R., et al. (2010). SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity. Cell Metab. 12, 78-87. doi: 10.1016/j.cmet.2010.05.010
119. Ramadori, G., Lee, C. E., Bookout, A. L., Lee, S., Williams, K. W., Anderson, J., et al. (2008). Brain SIRT1: anatomical distribution and regulation by energy availability. J. Neurosci. 28, 9989-9996. doi: 10.1523/jneurosci.3257-08.2008
120. Ramsey, K. M., Yoshino, J., Brace, C. S., Abrassart, D., Kobayashi, Y., Marcheva, B., et al. (2009). Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 324, 651-654. doi: 10.1126/science.1171641
121. Rardin, M. J., He, W., Nishida, Y., Newman, J. C., Carrico, C., Danielson, S. R., et al. (2013). SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab. 18, 920-933. doi: 10.1016/j.cmet.2013.11.013
122. Raval, A. P., Dave, K. R., and Pérez-Pinzón, M. A. (2006). Resveratrol mimics ischemic preconditioning in the brain. J. Cereb. Blood Flow Metab. 26, 1141-1147. doi: 10.1038/sj.jcbfm.9600262
123. Revilla, S., Suñol, C., García-Mesa, Y., Giménez-Llort, L., Sanfeliu, C., and Cristòfol, R. (2014). Physical exercise improves synaptic dysfunction and recovers the loss of survival factors in 3xTg-AD mouse brain. Neuropharmacology 81, 55-63. doi: 10.1016/j.neuropharm.2014.01.037
124. Rey, G., and Reddy, A. B. (2013). Connecting cellular metabolism to circadian clocks. Trends Cell Biol. 23, 234-241. doi: 10.1016/j.tcb.2013.01.003
125. Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., and Puigserver, P. (2005). Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434, 113-118. doi: 10.1038/nature03354
126. Rogina, B., and Helfand, S. L. (2004). Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. U S A 101, 15998-16003. doi: 10.1073/pnas.0404184101
127. Saharan, S., Jhaveri, D. J., and Bartlett, P. F. (2013). SIRT1 regulates the neurogenic potential of neural precursors in the adult subventricular zone and hippocampus. J. Neurosci. Res. 91, 642-659. doi: 10.1002/jnr.23199
128. Sakamoto, J., Miura, T., Shimamoto, K., and Horio, Y. (2004). Predominant expression of Sir2alpha, an NAD-dependent histone deacetylase, in the embryonic mouse heart and brain. FEBS Lett. 556, 281-286. doi: 10.1016/s0014-5793(03)01444-3
129. Sansone, L., Reali, V., Pellegrini, L., Villanova, L., Aventaggiato, M., Marfe, G., et al. (2013). SIRT1 silencing confers neuroprotection through IGF-1 pathway activation. J. Cell. Physiol. 228, 1754-1761. doi: 10.1002/jcp.24334
130. Sasaki, T., Kikuchi, O., Shimpuku, M., Susanti, V. Y., Yokota-Hashimoto, H., Taguchi, R., et al. (2014). Hypothalamic SIRT1 prevents age-associated weight gain by improving leptin sensitivity in mice. Diabetologia 57, 819-831. doi: 10.1007/s00125-013-3140-5
131. Sasaki, T., Kim, H. J., Kobayashi, M., Kitamura, Y. I., Yokota-Hashimoto, H., Shiuchi, T., et al. (2010). Induction of hypothalamic Sirt1 leads to cessation of feeding via agouti-related peptide. Endocrinology 151, 2556-2566. doi: 10.1210/en.2009-1319
132. Satoh, A., Brace, C. S., Ben-Josef, G., West, T., Wozniak, D. F., Holtzman, D. M., et al. (2010). SIRT1 promotes the central adaptive response to diet restriction through activation of the dorsomedial and lateral nuclei of the hypothalamus. J. Neurosci. 30, 10220-10232. doi: 10.1523/jneurosci.1385-10.2010
133. Satoh, A., Brace, C. S., Rensing, N., Cliften, P., Wozniak, D. F., Herzog, E. D., et al. (2013). Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab. 18, 416-430. doi: 10.1016/j.cmet.2013.07.013
134. Schenk, S., McCurdy, C. E., Philp, A., Chen, M. Z., Holliday, M. J., Bandyopadhyay, G. K., et al. (2011). Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction. J. Clin. Invest. 121, 4281-4288. doi: 10.1172/JCI58554
135. Schratt, G. M., Tuebing, F., Nigh, E. A., Kane, C. G., Sabatini, M. E., Kiebler, M., et al. (2006). A brain-specific microRNA regulates dendritic spine development. Nature 439, 283-289. doi: 10.1038/nature04367
136. Sebastián, C., Satterstrom, F. K., Haigis, M. C., and Mostoslavsky, R. (2012). From sirtuin biology to human diseases: an update. J. Biol. Chem. 287, 42444-42452. doi: 10.1074/jbc.r112.402768
137. Shan, T., Wang, Y., Wu, T., Liu, C., Guo, J., Zhang, Y., et al. (2009). Porcine sirtuin 1 gene clone, expression pattern and regulation by resveratrol. J. Anim. Sci. 87, 895-904. doi: 10.2527/jas.2008-1344
138. Sinclair, D. A., and Guarente, L. (1997). Extrachromosomal rDNA circles-a cause of aging in yeast. Cell 91, 1033-1042. doi: 10.1016/s0092-8674(00)80493-6
139. Smith, M. R., Syed, A., Lukacsovich, T., Purcell, J., Barbaro, B. A., Worthge, S. A., et al. (2014). A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease. Hum. Mol. Genet. 23, 2995-3007. doi: 10.1093/hmg/ddu010
140. Song, L., Chen, L., Zhang, X., Li, J., and Le, W. (2014). Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Biomed. Res. Int. 2014:483501. doi: 10.1155/2014/483501
141. Srivastava, S., and Haigis, M. C. (2011). Role of sirtuins and calorie restriction in neuroprotection: implications in Alzheimer's and Parkinson's diseases. Curr. Pharm. Des. 17, 3418-3433. doi: 10.2174/138161211798072526
142. Sugden, M. C., Caton, P. W., and Holness, M. J. (2010). PPAR control: it's SIRTainly as easy as PGC. J. Endocrinol. 204, 93-104. doi: 10.1677/joe-09-0359
143. Sugino, T., Maruyama, M., Tanno, M., Kuno, A., Houkin, K., and Horio, Y. (2010). Protein deacetylase SIRT1 in the cytoplasm promotes nerve growth factor-induced neurite outgrowth in PC12 cells. FEBS Lett. 584, 2821-2826. doi: 10.1016/j.neures.2010.07.1100
144. Sun, J. H., Yu, J. T., and Tan, L. (2014). The role of cholesterol metabolism in Alzheimer's disease. Mol. Neurobiol. doi: 10.1007/s12035-014-8749-y. [Epub ahead of print].
145. Tang, B. L. (2009). Sirt1's complex roles in neuroprotection. Cell. Mol. Neurobiol. 29, 1093-1103. doi: 10.1007/s10571-009-9414-2
146. Tang, B. L. (2011). Sirt1's systemic protective roles and its promise as a target in antiaging medicine. Transl. Res. 157, 276-284. doi: 10.1016/j.trsl.2010.11.006
147. Theendakara, V., Patent, A., Peters Libeu, C. A., Philpot, B., Flores, S., Descamps, O., et al. (2013). Neuroprotective Sirtuin ratio reversed by ApoE4. Proc. Natl. Acad. Sci. U S A 110, 18303-18308. doi: 10.1073/pnas.1314145110
148. Tiberi, L., van den Ameele, J., Dimidschstein, J., Piccirilli, J., Gall, D., Herpoel, A., et al. (2012). BCL6 controls neurogenesis through Sirt1-dependent epigenetic repression of selective Notch targets. Nat. Neurosci. 15, 1627-1635. doi: 10.1038/nn.3264
149. Tissenbaum, H. A., and Guarente, L. (2001). Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227-230. doi: 10.1038/35065638
150. Tong, X. K., Nicolakakis, N., Fernandes, P., Ongali, B., Brouillette, J., Quirion, R., et al. (2009). Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice. Neurobiol. Dis. 35, 406-414. doi: 10.1016/j.nbd.2009.06.003
151. Toorie, A. M., and Nillni, E. A. (2014). Minireview: central Sirt1 regulates energy balance via the melanocortin system and alternate pathways. Mol. Endocrinol. 28, 1423-1434. doi: 10.1210/me.2014-1115
152. van Ham, T. J., Thijssen, K. L., Breitling, R., Hofstra, R. M. W., Plasterk, R. H. A., and Nollen, E. A. A. (2008). C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet. 4:e1000027. doi: 10.1371/journal.pgen.1000027
153. Viswanathan, M., and Guarente, L. (2011). Regulation of Caenorhabditis elegans lifespan by sir-2.1 transgenes. Nature 477, E1-E2. doi: 10.1038/nature10440
154. Wang, W., Esbensen, Y., Kunke, D., Suganthan, R., Rachek, L., Bjørås, M., et al. (2011). Mitochondrial DNA damage level determines neural stem cell differentiation fate. J. Neurosci. 31, 9746-9751. doi: 10.1523/jneurosci.0852-11.2011
155. Wang, J., Ho, L., Qin, W., Rocher, A. B., Seror, I., Humala, N., et al. (2005). Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer's disease. FASEB J. 19, 659-661. doi: 10.1096/fj.04-3182fje
156. Weir, H. J. M., Lane, J. D., and Balthasar, N. (2013). SIRT3: a central regulator of mitochondrial adaptation in health and disease. Genes Cancer 4, 118-124. doi: 10.1177/1947601913476949
157. Wolkow, C. A., Kimura, K. D., Lee, M. S., and Ruvkun, G. (2000). Regulation of C. elegans life-span by insulinlike signaling in the nervous system. Science 290, 147-150. doi: 10.1126/science.290.5489.147
158. Wood, W. G., Li, L., Müller, W. E., and Eckert, G. P. (2014). Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis. J. Neurochem. 129, 559-572. doi: 10.1111/jnc.12637
159. Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., et al. (2004). Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686-689. doi: 10.1038/nature02789
160. Wu, D., Qiu, Y., Gao, X., Yuan, X. B., and Zhai, Q. (2011). Overexpression of SIRT1 in mouse forebrain impairs lipid/glucose metabolism and motor function. PLoS One 6:e21759. doi: 10.1371/journal.pone.0021759
161. Wu, A., Ying, Z., and Gomez-Pinilla, F. (2006). Oxidative stress modulates Sir2alpha in rat hippocampus and cerebral cortex. Eur. J. Neurosci. 23, 2573-2580. doi: 10.1111/j.1460-9568.2006.04807.x
162. Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., et al. (2004). Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369-2380. doi: 10.1038/sj.emboj.7600244
163. Zakhary, S. M., Ayubcha, D., Dileo, J. N., Jose, R., Leheste, J. R., Horowitz, J. M., et al. (2010). Distribution analysis of deacetylase SIRT1 in rodent and human nervous systems. Anat. Rec. (Hoboken) 293, 1024-1032. doi: 10.1002/ar.21116
164. Zhang, Y., Wang, J., Chen, G., Fan, D., and Deng, M. (2011a). Inhibition of Sirt1 promotes neural progenitors toward motoneuron differentiation from human embryonic stem cells. Biochem. Biophys. Res. Commun. 404, 610-614. doi: 10.1016/j.bbrc.2010.12.014
165. Zhang, F., Wang, S., Gan, L., Vosler, P. S., Gao, Y., Zigmond, M. J., et al. (2011b). Protective effects and mechanisms of sirtuins in the nervous system. Prog. Neurobiol. 95, 373-395. doi: 10.1016/j.pneurobio.2011.09.001
166. Zhao, Y., Luo, P., Guo, Q., Li, S., Zhang, L., Zhao, M., et al. (2012). Interactions between SIRT1 and MAPK/ERK regulate neuronal apoptosis induced by traumatic brain injury in vitro and in vivo. Exp. Neurol. 237, 489-498. doi: 10.1016/j.expneurol.2012.07.004
167. Zocchi, L., and Sassone-Corsi, P. (2012). SIRT1-mediated deacetylation of MeCP2 contributes to BDNF expression. Epigenetics 7, 695-700. doi: 10.4161/epi.20733
168. Zovkic, I. B., Paulukaitis, B. S., Day, J. J., Etikala, D. M., and Sweatt, J. D. (2014). Histone H2A.Z subunit exchange controls consolidation of recent and remote memory. Nature 515, 582-586. doi: 10.1038/nature13707